Kazia Therapeutics is an oncology-focused biotechnology company, developing innovative anti-cancer drugs. Headquartered in Sydney, Australia, Kazia Therapeutics collaborates with leading scientists, clinicians, and investors around the world.

Biotechnology

Kazia Therapeutics

Kazia Therapeutics' headquarters in Sydney, Australia

Robert Kennedy

John Friend

Chinar Patel

Michael Fitzgerald

Dominic Capone

Steven Coffey

Bryce Carmine

Iain Ross

Kate Hill

Peter Gunning

Murray Brennan

Karen Ferrante

Alex Matter

The Scientific Advisory Team at Kazia Therapeutics comprises experienced scientific advisors who provide expert guidance on research and development strategies for innovative anti-cancer therapies. They collaborate closely with internal teams and external partners to ensure that the company's projects align with the latest scientific advancements and clinical needs, facilitating informed decision-making throughout the drug development process.

Scientific Advisory Team

The Leadership Team at Kazia Therapeutics drives the strategic vision and operational excellence of the company, ensuring alignment with its mission to develop innovative anti-cancer therapies. Comprising key executives like the CEO and VP of Corporate Relations, this team fosters collaboration with scientific and clinical partners while navigating investment opportunities to advance the company's research and commercialization efforts in oncology.

Leadership Team

Kazia Therapeutics

Org chart

Board & advisors

Teams

Scientific Advisory Team

Leadership Team

Offices

Kazia Therapeutics

Org chart

Board & advisors

Teams

Scientific Advisory Team

Leadership Team

Offices

Related companies